- Wang Y, Wu Y, Xiang L, Xu C, Lau CW, Zhang C, Deng D, Liu J, Xia Y, Ma RWC, Huang Y, *Wang L (2025) Inhibition of the YAP-E2F2-FGF2 Axis in Renal Tubular Cells Ameliorates Renal Fibrosis in Chronic Kidney Disease. Science China - Life Sciences Accepted: Feb 20, 2025 Available online: Mar 18, 2025
- Xiang L, Wang L, Xia Y, Wang Y, Shui J, Zhang CL, Xie L, Ru Y, Cheng CK, Pu Y, Hu L, Liu J, Xu S, Cai ZW, Huang Y (2024) Exercise Alleviates Diabetic Kidney Disease Through PPARd-CPT1a pathway-dependent Fatty Acid β-oxidation. The Innovation Life 2(2):100065 (10 pages)
- Liu Y, Wang Y, Xu C, Zhang Y, Wang Y, Qin J, Lan HY, Wang L, Huang Y, Mak K, Zheng Z, Xia Y (2024) Activation of the YAP/KLF5 transcriptional cascade in renal tubular cells aggravates kidney injury. Molecular Therapy 32(5):1526-1539.
- Cheng CK, Lin X, Pu Y, Tse KYJ, Wang Y, Zhang CL, Cao X, Lau CW, Huang J, He L, Luo JY, Shih YT, Wan S, Ng CF, Wang L, Ma CWR, JJ Chiu, Chan TF, Tian XY & Huang Y (2022) SOX4 is a novel phenotypic regulator of endothelial cells in atherosclerosis revealed by single-cell analysis. Journal of Advanced Research (In press)
- Xiang L, Nie J, Wang L, Wang Y, Shi J, Wei J, Lau CW, Cai ZW & Huang Y (2021) Integrated metabolomics analysis of the effect of PPARd agonist GW501516 on catabolism of BCAAs and carboxylic acids in diabetic mice. Chinese Chemical Letters 32(7):2197-2202.
|
